Cargando…
CD147 monoclonal antibody mediated by chitosan nanoparticles loaded with α-hederin enhances antineoplastic activity and cellular uptake in liver cancer cells
An antibody that specifically interacts with an antigen could be applied to an active targeting delivery system. In this study, CD147 antibody was coupled with α-hed chitosan nanoparticles (α-Hed-CS-NPs). α-Hed-CS-CD147-NPs were round and spherical in shape, with an average particle size of 148.23 ±...
Autores principales: | Zhu, Rong, Zhang, Chun-ge, Liu, Yang, Yuan, Zhi-qiang, Chen, Wei-liang, Yang, Shu-di, Li, Ji-zhao, Zhu, Wen-jing, Zhou, Xiao-feng, You, Ben-gang, Zhang, Xue-nong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671144/ https://www.ncbi.nlm.nih.gov/pubmed/26639052 http://dx.doi.org/10.1038/srep17904 |
Ejemplares similares
-
Synthesis and Tumor Cytotoxicity of Novel Amide Derivatives of β-Hederin
por: Liu, Yang, et al.
Publicado: (2010) -
D Rhamnose β-Hederin against human breast cancer by reducing tumor-derived exosomes
por: Chen, Wei-Xian, et al.
Publicado: (2018) -
Targeting CD147 for T to NK Lineage Reprogramming and Tumor Therapy
por: Geng, Jie-Jie, et al.
Publicado: (2017) -
CD147 blockade as a potential and novel treatment of graft rejection
por: Luan, Jing, et al.
Publicado: (2017) -
Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311
por: Burger, A M, et al.
Publicado: (1999)